The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Formation of Polyglutamine Inclusions in Non-CNS Tissue
Abstract
Huntington's disease (HD) is one of a class of inherited progressive neurodegenerative disorders that are caused by a CAG/polyglutamine repeat expansion. We have previously generated mice that are transgenic for exon 1 of the HD gene carrying highly expanded CAG repeats which develop a progressive movement disorder and weight loss with similarities to HD. Neuronal inclusions composed of the exon 1 protein and ubiquitin are present in specific brain regions prior to onset of the phenotype, which in turn occurs long before specific neurodegeneration can be detected. In this report we have extended the search for polyglutamine inclusions to non-neuronal tissues. Outside the central nervous system (CNS), inclusions were identified in a variety of post-mitotic cells. This is consistent with a concentration-dependent nucleation and aggregation model of inclusion formation and indicates that brain-specific factors are not necessary for this process. To possibly gain insights into the wasting that is observed in the human disease, we have conducted a detailed analysis of the timing and progression of inclusion formation in skeletal muscle and an investigation into the cause of the severe muscle atrophy that occurs in the mouse model. The formation of inclusions in non-CNS tissues will be particularly useful with respect to in vivo monitoring of pharmaceutical agents selected for their ability to prevent polyglutamine aggregation in vitro, without the requirement that the agent can cross the blood-brain barrier in the first instance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Self-citationAggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Self-citationDavies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Self-citationScherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291 · cited 3×
“Evidence from (i) immunohistochemistry on post-mortem brain material with antibodies spanning the huntingtin protein (11‐13), (ii) cell culture models transfected with various portions of huntingtin ( 24‐28) and (iii) in vitro aggregation experiments ( 8 ) indicates that it is an N-terminal fragment of huntingtin that…”
BackgroundInfluentialSelf-citationGlutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.
Perutz, M. F., Johnson, T., Suzuki, M., & Finch, J. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5355 · Cited by 1,062
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Self-citationIntranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3
Paulson, H. L., Perez, M. K., Trottier, Y., Trojanowski, J. Q., Subramony, S. H., Das, S. S., Vig, P., Mandel, J.-L., Fischbeck, K. H., & Pittman, R. N. (1997) · Neuron · doi:10.1016/s0896-6273(00)80943-5 · Cited by 830
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy
Brais, B., Bouchard, J.-P., Xie, Y.-G., Rochefort, D. L., Chrétien, N., Tomé, F. M. S., Lafrentére, R. G., Rommens, J. M., Uyama, E., Nohira, O., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-164 · Cited by 805
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Cummings, C. J., Mancini, M. A., Antalffy, B., DeFranco, D. B., Orr, H. T., & Zoghbi, H. Y. (1998) · Nature Genetics · doi:10.1038/502 · Cited by 744
Scherzinger, E., Sittler, A., Schweiger, K., Heiser, V., Lurz, R., Hasenbank, R., Bates, G. P., Lehrach, H., & Wanker, E. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4604 · Cited by 705
Self-citationGurd, A., & Wilson, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91669-8 · Cited by 526
Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
Skinner, P. J., Koshy, B. T., Cummings, C. J., Klement, I. A., Helin, K., Servadio, A., Zoghbi, H. Y., & Orr, H. T. (1997) · Nature · doi:10.1038/40153 · Cited by 523
Widespread expression of Huntington's disease gene (IT15) protein product
Sharp, A. H., Loev, S. J., Schilling, G., Li, S.-H., Li, X.-J., Bao, J., Wagster, M. V., Kotzuk, J. A., Steiner, J. P., Lo, A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90345-3 · Cited by 513
Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Self-citationMartindale, D., Hackam, A., Wieczorek, A., Ellerby, L., Wellington, C., McCutcheon, K., Singaraja, R., Kazemi-Esfarjani, P., Devon, R., Kim, S. U., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-150 · Cited by 485
Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E. C., & Mandel, J.-L. (1995) · Nature Genetics · doi:10.1038/ng0595-104 · Cited by 452
Becher, M. W., Kotzuk, J. A., Sharp, A. H., Davies, S. W., Bates, G. P., Price, D. L., & Ross, C. A. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0168 · Cited by 433
Self-citationWidespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues
Strong, T. V., Tagle, D. A., Valdes, J. M., Elmer, L. W., Boehm, K., Swaroop, M., Kaatz, K. W., Collins, F. S., & Albin, R. L. (1993) · Nature Genetics · doi:10.1038/ng1193-259 · Cited by 416
Cooper, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.783 · Cited by 375
Ordway, J. M., Tallaksen-Greene, S., Gutekunst, C.-A., Bernstein, E. M., Cearley, J. A., Wiener, H. W., Dure, L. S., Lindsey, R., Hersch, S. M., Jope, R. S., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80464-x · Cited by 370
Igarashi, S., Koide, R., Shimohata, T., Yamada, M., Hayashi, Y., Takano, H., Date, H., Oyake, M., Sato, T., Sato, A., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-111 · Cited by 355
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
Clark, A., Lewis, C. E., Willis, A. C., Cooper, G. J. S., Morris, J. F., Reid, K. B. M., & Turner, R. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90825-7 · Cited by 350
Holmberg, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.913 · Cited by 337
Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy
Li, M., Miwa, S., Kobayashi, Y., Merry, D. E., Yamamoto, M., Tanaka, F., Doyu, M., Hashizum, Y., Fischbeck, K. H., & Sobue, G. (1998) · Annals of Neurology · doi:10.1002/ana.410440216 · Cited by 334
Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation
Mangiarini, L., Sathasivam, K., Mahal, A., Mott, R., Seller, M., & Bates, G. P. (1997) · Nature Genetics · doi:10.1038/ng0297-197 · Cited by 318
Self-citationThe Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity
Hackam, A. S., Singaraja, R., Wellington, C. L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M., & Hayden, M. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1097 · Cited by 313
Genetic instabilities and hereditary neurological diseases
Wells, R. D., Warren, S. T., & Sarmiento, M. (1998) · Cited by 269
Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.
Hurlbert, M. S., Zhou, W., Wasmeier, C., Kaddis, F. G., Hutton, J. C., & Freed, C. R. (1999) · Diabetes · doi:10.2337/diabetes.48.3.649 · Cited by 218
A cellular model that recapitulates major pathogenic steps of Huntington's disease
Lunkes, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1355 · Cited by 189
Diabetes mellitus in Huntington disease
Farrer, L. A. (1985) · Clinical Genetics · doi:10.1111/j.1399-0004.1985.tb00185.x · Cited by 170 · cited 1×
“It is interesting that an increase in the frequency of diabetes in HD patients, as compared with the normal population, has been reported ( 44 ), although it is not known whether this is related to polyQ amyloid deposition.”
BackgroundStructural Neurology: Are Seeds at the Root of Neuronal Degeneration?
Lansbury, P. T. (1997) · Neuron · doi:10.1016/s0896-6273(00)80406-7 · Cited by 170
Missense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients
Sakagashira, S., Sanke, T., Hanabusa, T., Shimomura, H., Ohagi, S., Kumagaye, K. Y., Nakajima, K., & Nanjo, K. (1996) · Diabetes · doi:10.2337/diab.45.9.1279 · Cited by 167
Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats
Li, S. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.777 · Cited by 162
BODY WEIGHT AND DIETARY FACTORS IN HUNTINGTON'S DISEASE PATIENTS COMPARED WITH MATCHED CONTROLS
Sanberg, P. R., Fibiger, H. C., & Mark, R. F. (1981) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1981.tb135681.x · Cited by 161
Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy.
Li, M., Nakagomi, Y., Kobayashi, Y., Merry, D., Tanaka, F., Doyu, M., Mitsuma, T., Hashizume, Y., Fischbeck, K., & Sobue, G. (1998) · American Journal of Pathology · doi:10.1016/s0002-9440(10)65612-x · Cited by 147
Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy
Tomé, F. M. S., Château, D., Helbling-Leclerc, A., & Fardeau, M. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00085-0 · Cited by 114
de Rooij, K. E., Dorsman, J. C., Smoor, M. A., Dunnen, J. T. D., & Ommen, G. J. V. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1093 · Cited by 114
Amyloid-β Deposition in Skeletal Muscle of Transgenic Mice
Fukuchi, K., Pham, D. G., Hart, M., Li, L., & Lindsey, J. R. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65682-9 · Cited by 91
Striking changes in anxiety in Huntington's disease transgenic mice
File, S. E., Mahal, A., Mangiarini, L., & Bates, G. P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00736-7 · Cited by 75
Self-citationTransgenic Mice in the Study of Polyglutamine Repeat Expansion Diseases
Bates, G. P., Mangiarini, L., & Davies, S. W. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00196.x · Cited by 75
Self-citationAskanas, V. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/030097498442208 · Cited by 68
Jin, L.-W., Hearn, M. G., Ogburn, C. E., Dang, N., Nochlin, D., Ladiges, W., & Martin, G. M. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65681-7 · Cited by 66
Huntington's disease.Preprint
Gusella, J. F., McNeil, S. M., Persichetti, F., Srinidhi, J., Novelletto, A., Bird, E. J., Faber, P. W., Vonsattel, J., Myers, R. H., & MacDonald, M. E. (1996) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1996.061.01.062 · Cited by 64
Neuronal distribution of intranuclear inclusions in Huntingtonʼs disease with adult onset
Gourfinkel‐An, I., Cancel‐Tassin, G., Duyckaerts, C. J., Faucheux, B. A., Hauw, J., Trottier, Y., Brice, A., Agid, Y., & Hirsch, É. C. (1998) · Neuroreport · doi:10.1097/00001756-199806010-00028 · Cited by 61
Cited by
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
Schöls, L., Bauer, P., Schmidt, T., Schulte, T., & Riess, O. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00737-9 · Cited by 1,058
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N. R., Doi, H., Kurosawa, M., Nekooki, M., & Nukina, N. (2004) · Nature Medicine · doi:10.1038/nm985 · Cited by 782
Björkqvist, M., Wild, E. J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R. V., Benn, C. L., Soulet, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080178 · Cited by 650
Self-citation
Metadata
- Authors
- Sathasivam, K., Hobbs, C., Turmaine, M., Mangiarini, L., Mahal, A., Bertaux, F., Wanker, E. E., Doherty, P., Davies, S. W., & Bates, G. P.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05-01
- Volume
- 8
- Issue
- 5
- Pages
- 813-822
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2137938929
- Cited by
- 289
- References
- 46
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.